Medicare Enrolled

Dr. Michael Boyd, M.D.

Neurology · Hinsdale, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
908 N ELM ST, Hinsdale, IL 60521
6308568640
In practice since 2009 (17 years)
NPI: 1891924999 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Boyd from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Boyd? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Boyd

Dr. Michael Boyd is a neurology specialist in Hinsdale, IL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Boyd performed 1,217 Medicare services across 1,072 unique beneficiaries.

Between the years covered by Open Payments, Dr. Boyd received a total of $8,035 from 41 pharmaceutical and/or device companies across 316 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Boyd is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 21% volume in IL $8,035 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,217
Medicare services
Top 21% in IL for neurology
1,072
Unique beneficiaries
$99
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~72 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
342 $95 $247
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
190 $124 $367
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
138 $139 $460
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
108 $63 $171
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
100 $98 $262
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
82 $65 $185
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
66 $76 $246
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
33 $45 $128
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
32 $146 $374
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
20 $159 $631
EEG brain wave monitoring, 41-60 minutes
This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes.
19 $44 $160
Limited needle EMG of arm or leg muscles
A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area.
18 $52 $158
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
17 $139 $530
New patient office visit, complex (60-74 min) 16 $138 $462
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
13 $45 $151
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
12 $108 $403
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
11 $108 $342
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,035
Total received (2018-2024)
Avg $1,148/year across 7 years
Top 24% in IL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
316
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,086 (63.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,455 (30.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$494 (6.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$799
2023
$1,134
2022
$1,901
2021
$802
2020
$138
2019
$433
2018
$2,830

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$268
Biogen, Inc.
$141
Teva Pharmaceuticals USA, Inc.
$137
SK Life Science, Inc.
$61
BANNER LIFE SCIENCES, LLC
$46
UCB, Inc.
$42
Novartis Pharmaceuticals Corporation
$41
Lundbeck LLC
$30
TG Therapeutics, Inc.
$18
Abbott Laboratories
$15
Top 3 companies account for 68.4% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$3,261
Teva Pharmaceuticals USA, Inc.
$1,021
ABBVIE INC.
$838
AbbVie Inc.
$398
UCB, Inc.
$277
GENZYME CORPORATION
$183
Novartis Pharmaceuticals Corporation
$174
Sunovion Pharmaceuticals Inc.
$155
SK Life Science, Inc.
$148
Supernus Pharmaceuticals, Inc.
$118
Allergan Inc.
$105
ACADIA Pharmaceuticals Inc
$100
Lilly USA, LLC
$99
SANOFI-AVENTIS U.S. LLC
$97
EMD Serono, Inc.
$88
LivaNova USA, Inc.
$86
BANNER LIFE SCIENCES, LLC
$80
Alexion Pharmaceuticals, Inc.
$79
Amgen Inc.
$72
Lundbeck LLC
$63
TG THERAPEUTICS, INC.
$59
Genentech USA, Inc.
$58
Acorda Therapeutics, Inc
$47
Kyowa Kirin, Inc.
$47
Avanir Pharmaceuticals, Inc.
$46
Bayer HealthCare Pharmaceuticals Inc.
$38
Biohaven Pharmaceuticals, Inc.
$30
Biohaven Pharmaceutical Holding Company Ltd.
$27
Alnylam Pharmaceuticals Inc.
$25
Banner Life Sciences, LLC
$23
Mallinckrodt LLC
$23
ARGENX US, INC.
$22
Grifols USA, LLC
$21
Allergan, Inc.
$19
IMPEL PHARMACEUTICALS INC.
$18
TG Therapeutics, Inc.
$18
Neurelis, Inc.
$17
Abbott Laboratories
$15
Upsher-Smith Laboratories LLC
$15
OWP Pharmaceuticals, Inc.
$15
Assertio Therapeutics, Inc.
$11
Top 3 companies account for 63.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Betaseron · Briviact · Cambia · EMGALITY · GILENYA · Gamunex-C · INBRIJA · INFINITY · KESIMPTA · Lamotrigine Starter Kit · Mavenclad · NAMZARIC · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · OCREVUS · ONPATTRO · OXTELLAR XR · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · Rebif · SOLIRIS · TECFIDERA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYEPTI · VYVGART HYTRULO · Vimpat
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (63%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Hinsdale?
Compare neurologists in the Hinsdale area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
620
Per 100K population
66.9
County median income
$110,502
Nearest hospital
UCHICAGO MEDICINE ADVENTHEALTH HINSDALE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Boyd is a clinical cardiology specialist, with above-average Medicare volume (top 21% in IL), with low-engagement industry engagement, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Boyd experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Boyd performed 342 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Boyd receive payments from pharmaceutical companies?
Yes. Dr. Boyd received a total of $8,035 from 41 companies across 316 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Boyd's costs compare to other neurologists in Hinsdale?
Dr. Boyd's average Medicare payment per service is $99. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Boyd) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →